{"nct_id":"NCT06100276","title":"Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)","status":"RECRUITING","status_verified_date":"2024-09","start_date":"2024-08-01","start_date_type":"ACTUAL","primary_completion_date":"2026-09-30","primary_completion_date_type":"ESTIMATED","completion_date":"2031-03-30","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["QURE"]}